Ankylosing Spondylitis - Pipeline Review, Q1 2011

Published by: Global Markets Direct

Published: Jan. 24, 2011 - 23 Pages


Table of Contents

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Ankylosing Spondylitis Overview
Therapeutics Development
An Overview of Pipeline Products for Ankylosing Spondylitis
Ankylosing Spondylitis Therapeutics under Development by Companies
Ankylosing Spondylitis Therapeutics under Investigation by Universities/Institutes
Companies Involved in Ankylosing Spondylitis Therapeutics Development
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Logical Therapeutics, Inc.
Celltrion Inc.
Universities/Institutes Involved in Ankylosing Spondylitis Therapeutics Development
Ankylosing Spondylitis Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles - Companies
LT-NS001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles - Universities/Institutes
Tripterygium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products Under Development for Ankylosing Spondylitis, 2011
Products under Development for Ankylosing Spondylitis - Comparative Analysis, 2011
Pfizer Inc., 2011
Regeneron Pharmaceuticals, Inc., 2011
Logical Therapeutics, Inc., 2011
Celltrion Inc., 2011
Assessment by Monotherapy Products, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Discontinued Products
List of Figures
Number of Products under Development for Ankylosing Spondylitis, 2011
Products under Development for Ankylosing Spondylitis - Comparative Analysis, 2011
Products under Development by Companies, 2011
Products under Investigation by Universities/Institutes, 2011
Assessment by Monotherapy Products, 2011
Assessment by Route of Administration, 2011
Assessment by Stage and Route of Administration, 2011
Assessment by Molecule Type, 2011
Assessment by Stage and Molecule Type, 2011

Abstract

Ankylosing Spondylitis - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Ankylosing Spondylitis - Pipeline Review, Q1 2011', provides an overview of the Ankylosing Spondylitis therapeutic pipeline. This report provides information on the therapeutic development for Ankylosing Spondylitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ankylosing Spondylitis. 'Ankylosing Spondylitis - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope
  • A snapshot of the global therapeutic scenario for Ankylosing Spondylitis.
  • A review of the Ankylosing Spondylitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Ankylosing Spondylitis pipeline on the basis of therapeutic class, route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Identify and understand important and diverse types of therapeutics under development for Ankylosing Spondylitis.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Ankylosing Spondylitis pipeline depth and focus of Ankylosing Spondylitis therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


Get full details about this report >>
 
Learn more about this product


Price and delivery options
Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.